1,411
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: CLINICAL ONCOLOGY

Feasibility, Safety and Impact of (18F)-FDG PET/CT in patients with pregnancy-associated cancer: experience of the French CALG (Cancer Associé à La Grossesse) network

, ORCID Icon, , , , , , , , , & show all
Pages 302-308 | Received 19 Jul 2021, Accepted 04 Nov 2021, Published online: 14 Nov 2021

References

  • Smith LH, Danielsen B, Allen ME, et al. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189(4):1128–1135.
  • Lee YY, Roberts CL, Dobbins T, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study. BJOG. 2012;119(13):1572–1582.
  • Parazzini F, Franchi M, Tavani A, et al. Frequency of pregnancy related cancer: a population based linkage study in Lombardy, Italy. Int J Gynecol Cancer. 2017;27(3):613–619.
  • Matthews TJ, Hamilton BE. First births to older women continue to rise. NCHS Data Brief. 2014;(152):1–8.
  • de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337–346.
  • Boudy AS, Zaccarini F, Selleret L, et al. Oncological management of pregnancy-associated cancers: analysis from the French CALG (Cancer Associé à La Grossesse) network. Acta Oncol. 2020;59(9):1043–1050.
  • Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1(8):1145–1153.
  • Peccatori FA, Azim HA Jr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi160–vi170.
  • Azim HA Jr, Santoro L, Russell-Edu W, et al. Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev. 2012;38(7):834–842.
  • Litton JK, Warneke CL, Hahn KM, et al. Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist. 2013;18(4):369–376.
  • Amant F, von Minckwitz G, Han SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013;31(20):2532–2539.
  • Umutlu L, Antoch G, Herrmann K, et al. PET/MR imaging of the female pelvis. Semin Nucl Med. 2019;49(6):512–520.
  • Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048–3058.
  • Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5(Suppl 5):v8–v30.
  • Takalkar AM, Khandelwal A, Lokitz S, et al. 18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med. 2011;52(7):1035–1040.
  • Zanotti-Fregonara P, Laforest R, Wallis JW. Fetal radiation dose from 18F-FDG in pregnant patients imaged with PET, PET/CT, and PET/MR. J Nucl Med. 2015;56(8):1218–1222.
  • Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–354.
  • Boudy AS, Naoura I, Selleret L, et al. Propensity score to evaluate prognosis in pregnancy-associated breast cancer: Analysis from a French cancer network. Breast. 2018;40:10–15.
  • Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy. Lancet. 2012;379(9815):570–579.
  • Sun Z, Yi YL, Liu Y, et al. Comparison of whole-body PET/PET-CT and conventional imaging procedures for distant metastasis staging in patients with breast cancer: a Meta-analysis. Eur J Gynaecol Oncol. 2015;36(6):672–676.
  • Taneja S, Jena A, Goel R, et al. Simultaneous whole-body 18F-FDG PET-MRI in primary staging of breast cancer: a pilot study. Eur J Radiol. 2014;83(12):2231–2239.
  • Sawicki LM, Grueneisen J, Schaarschmidt BM, et al. Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer. Eur J Radiol. 2016;85(2):459–465.
  • Pujara AC, Kim E, Axelrod D, et al. PET/MRI in breast cancer. J Magn Reson Imaging. 2019;49(2):328–342.
  • Ray JG, Vermeulen MJ, Bharatha A, et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016;316(9):952–961.
  • Mervak BM, Altun E, McGinty KA, et al. MRI in pregnancy: Indications and practical considerations. J Magn Reson Imaging. 2019;49(3):621–631.
  • Tirada N, Dreizin D, Khati NJ, et al. Imaging pregnant and lactating patients. Radiographics. 2015;35(6):1751–1765.
  • Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13(9):887–896.
  • Boudy AS, Naoura I, Zilberman S, et al. Arguments pour différencier les cancers du sein associés à la grossesse de ceux diagnostiqués dans le post-partum: expérience monocentrique du réseau cancer associé à la grossesse (CALG) [clues to differentiate pregnancy-associated breast cancer from those diagnosed in postpartum period: a monocentric experience of pregnancy-associated cancer network (CALG)]. Bull Cancer. 2017;104(6):574–584.
  • Xie T, Zanotti-Fregonara P, Edet-Sanson A, et al. Patient-specific computational model and dosimetry calculations for PET/CT of a patient pregnant with twins. J Nucl Med. 2018;59(9):1451–1458.
  • Gill MM, Sia W, Hoskinson M, et al. The use of PET/CT in pregnancy: a case report of malignant parathyroid carcinoma and a review of the literature. Obstet Med. 2018;11(1):45–49.
  • Zanotti-Fregonara P, Chastan M, Edet-Sanson A, et al. New fetal dose estimates from 18F-FDG administered during pregnancy: standardization of dose calculations and estimations with voxel-based anthropomorphic phantoms. J Nucl Med. 2016;57(11):1760–1763.
  • Xie T, Zaidi H. Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes. J Nucl Med. 2014;55(9):1459–1466.
  • Sawatzke AB, Norris AW, Spyropoulos F, et al. PET/CT imaging reveals unrivaled placental avidity for glucose compared to other tissues. Placenta. 2015;36(2):115–120.
  • Brent RL. Protection of the gametes embryo/fetus from prenatal radiation exposure. Health Phys. 2015;108(2):242–274.
  • Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6(5):328–333.
  • International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP. 2000;30(1):iii–viii, 1–43.
  • Streffer C, Shore R, Konermann G, et al. Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection. Ann ICRP. 2003;33(1–2):5–206.
  • Otake M, Schull WJ, Lee S. Threshold for radiation-related severe mental retardation in prenatally exposed A-bomb survivors: a re-analysis. Int J Radiat Biol. 1996;70(6):755–763.
  • Zanotti-Fregonara P, Stabin MG. New fetal radiation doses for 18F-FDG based on human data. J Nucl Med. 2017;58(11):1865–1866.
  • Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70:130–139.
  • Brent RL. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy. Am J Obstet Gynecol. 2009;200(1):4–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.